Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,556
Closed -$16K 5137
2022
Q1
$16K Sell
3,556
-23,016
-87% -$116K ﹤0.01% 4502
2021
Q4
$192K Sell
26,572
-26,375
-50% -$235K ﹤0.01% 3582
2021
Q3
$570K Buy
52,947
+50,019
+1,708% +$651K ﹤0.01% 3121
2021
Q2
$51K Sell
2,928
-13,878
-83% -$243K ﹤0.01% 4123
2021
Q1
$357K Buy
16,806
+10,316
+159% +$174K ﹤0.01% 3393
2020
Q4
$86K Sell
6,490
-5,324
-45% -$57.4K ﹤0.01% 4197
2020
Q3
$104K Buy
11,814
+780
+7% +$7.7K ﹤0.01% 4232
2020
Q2
$110K Buy
+11,034
New +$119K ﹤0.01% 4448
2019
Q4
Sell
-6
Closed 6549
2019
Q3
$0 Buy
+6
New +$39 ﹤0.01% 6884
2014
Q2
Sell
-385
Closed -$3K 7684
2014
Q1
$3K Buy
+385
New +$4.4K ﹤0.01% 7330

Other funds holding ICAD

Barclays's ICAD Position: Q2 2022 in Review

Barclays sold out of iCAD Inc (ICAD) in Q2 2022, closing a stake of 3,556 shares — an estimated $16K sold.

Barclays first reported a position in ICAD in Q1 2014 and held it in 10 quarters. The position peaked at $570K in Q3 2021. 67 funds tracked by Wall St. Rank hold ICAD as of Q2 2022.

  • Barclays reported no remaining iCAD Inc position as of Q2 2022 after selling out during the quarter.
  • Barclays sold 3,556 iCAD Inc shares in Q2 2022, an estimated $16K.
  • Barclays first reported a position in iCAD Inc in Q1 2014 and held it in 10 quarters.
  • Barclays's iCAD Inc position peaked at $570K in Q3 2021.
  • 67 funds tracked by Wall St. Rank held iCAD Inc as of Q2 2022.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.